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Introduction
In chronic hepatitis C (CHC), blood CD4 + T and CD8 + T cell responses have limited impact on disease course [1] [2] [3] but intra-hepatic T lymphocytes seem to control disease pathogenesis [4] [5] [6] . Therefore, regulation of intra-hepatic T cell responses in Hepatitis C Virus (HCV) patients may have important implication not only in determining spontaneous clearance but also in disease progression during chronic infection [7] [8] [9] .
It is well known that CD4 + CD25 + T cells are activated by microbial infections, leading to an overall increase of antiinflammatory cytokines. The increase in these cytokines induces the suppressive functions of CD4 + CD25 + natural regulatory T cells (Treg) [10] [11] [12] [13] [14] and could promote their local survival or retention [15] . Finally, infections disturb balance between natural Treg and effector lymphocytes, thereby alter immune response and may contribute to disease progression.
It has been shown that HCV patients have a higher number of Treg in peripheral blood than healthy patients [16] [17] [18] . When the natural Treg pressure is removed, the effector function of CD8 + T cells is restored and viral load is considerably reduced [19] . Depletion of CD4 + CD25 + T cells enhances antigenspecific CD4 + T and CD8 + T proliferation and response [11, 18, 20] . All these data have demonstrated that Treg play a key role in HCV disease.
Nowadays, Treg defined as CD4 + CD25 + are also characterized by expression of the transcriptional factor Forkhead box Protein 3 (FoxP3) [21, 22] . Comparisons of CD4 + CD25 + FoxP3 + Treg between infected and uninfected-HCV patients show that they are phenotypically, functionally and genetically indistinguishable [23, 24] . Among HCV-infected patients, HCV-specific FoxP3 + Treg are detected in the blood and have the capacity to suppress HCV-specific T cells [23] .
Previous in vitro data point out the presence of Treg expressing CD8 with regulatory ability [25] [26] [27] . Nevertheless, frequency and biological role of human CD8 + FoxP3 + T cells is less understood than their CD4 + CD25 + FoxP3 + T counterparts. Stimulation of peripheral blood mononuclear cells (PBMC) with HCV peptides reveals the presence of both virus-specific CD8 + FoxP3and CD8 + FoxP3 + T cells. CD8 + FoxP3 + T cells have proliferative capacity and display a cellcell contact-dependent suppressive activity [28] .
In HCV infection, most of studies are focused on peripheral Treg which probably do not reflect the precise composition and functions of these cells in the liver. In order to examine the physiopathological implication of intra-hepatic Treg during CHC, we evaluated their ex vivo phenotype, frequency and histological localization by immunohistochemistry and flow cytometry, and quantified intra-hepatic cytokines by RT-PCR, in relation to virological and histological parameters.
Patients and Methods

Patients and Material
Liver biopsies from chronically HCVinfected patients seen in Grenoble Hospital were selected from 2003 to 2005. Each patient had serological markers of HCV infection and presence of HCV RNA in serum. They were naïve of current or past immunomodulatory or antiviral treatment and had a frozen liver sample available. Fresh liver biopsies obtained by using 1.5 mm diameter disposable needle biopsy were divided into one part for histopathological examination (activity grading and fibrosis staging according to Metavir scoring system assessed by an experienced liver pathologist) and another part for immunological analyses. Blood samples from patients were collected at time of biopsy in heparinized vacutainer tubes. In practice, 47 frozen liver samples were retrospectively available for quantitative RT-PCR analyses and immunohistochemical analyses were performed in a sub-group of 20 formalin-fixed biopsies. Eight additional liver biopsies were prospectively included for exclusive flow cytometry analysis which needed fresh tissue samples and larger amount of cells for phenotyping (Table 1) . Criteria for exclusion were age under 18 years, presence of AgHBs or anti-HIV antibodies, other causes of chronic liver disease, alcohol consumption higher than 30 g/day. The study was in agreement with the recommendations of the local ethics committee and all patients gave written informed consent.
Double immunohistochemical analysis
Double immunohistochemical labeling was performed manually (Sequenza station) on 20 formalin-fixed, paraffinembedded liver biopsies. Two methods of immunodetection were applied: streptavidinbiotin-peroxydase (SBP) method with diaminobenzidine (DAB) as chromogen and streptavidin-biotin-alkaline phosphatase (SBAP) method with fast blue (FB) as chromogen.
For CD8/FoxP3 double staining, primary mouse anti-CD8 antibody (CD8, clone C8/144B, 1/100, Dako, Carpinteria, USA) and secondary biotinylated goat antimouse antibody (1/500, Jackson ImmunoResearch, West Grove, USA) were used, followed by detection with SBAP complex (1/50, Dako) and FB chromogen staining. For FoxP3 staining, primary mouse antibody (FoxP3, 1/20, Abcam, Cambridge, UK) and secondary biotinylated goat antimouse antibody (1/500, Jackson ImmunoResearch) were used, and detection was performed with SBP complex (1/200, Dako) and DAB chromogen staining.
For CD4/FoxP3 double staining, primary mouse antibody (CD4, clone 4B12, 1/75, Novocastra, Newcastle, UK), endogenous peroxydase inhibition, incubation with secondary biotinylated goat anti-mouse antibody, detection with SBP complex and DAB chromogen staining were performed. The second immunostaining with FoxP3 was performed as above with SBAP method and FB staining. Staining with an unrelated primary antibody (mouse IgG, 2 µg/ml, Jackson ImmunoResearch) provided a negative control for each reaction.
Positive cells were counted on a computer screen in consecutive fields along the whole section of the biopsy as described previously [29] , with the help of automatic software LUCIA (Laboratory Universal Computer Image Analysis, version 5.0, Laboratory Imaging, Prague, Czech Republic). Cell counts were performed by a single liver pathologist (NS) on serial sections obtained from paraffin blocks. Recorded parameters included total number of CD8 + , CD4 + and FoxP3 + cells, and distribution of FoxP3 + cells in fibrotic tissue (fibrous septa and portal tracts), in parenchymatous areas (lobules or nodules) and in foci of piecemeal or lobular necrosis. Results were expressed as number of cells per field, at magnification X20 (1.002 mm 2 ). 
RT-PCR analysis
Total RNA (5-10 mg) was extracted from 47 frozen liver biopsies, by homogenization of tissues in silica balls using MagnaLyser System (Roche Diagnostics, Meylan, France). The mixture was filtered on a silica column and "digested" by DNase I. Single-stranded cDNA was synthesized from 5-10 µg of total RNA by using the Superscript II Reverse Transcriptase (Gibco BRL, Life Technologies, Bethesda, USA). Primer pairs and probes for quantification of CD4, CD8-β, FoxP3, IL-10, IFN-γ, TGF-β, and TNF-α genes ( 
Immunostaining and flow cytometry analysis
Immunophenotyping was performed on 8 paired PBMC and liver samples with mouse monoclonal anti-FoxP3-PE (Human/Non Human Primate Regulatory T Cells Staining Kit -BD Biosciences, Pont de Claix, France), anti-human CD4-APC, antihuman CD8-FITC and anti-human CD25-PC7 (Beckman Coulter, Villepinte, France) antibodies. PBMC were isolated by density centrifugation over Ficoll gradients. Fresh tissues were washed and disrupted mechanically. Immunostaining and flow cytometry analyses were done as previously described [30] [31] [32] . Briefly, we selected total viable lymphocytes (1) by excluding dead cells after propidium iodide staining and (2) by gating PBMC and intra-hepatic cells on the basis of the forward and side scatting, after checking their anti-human CD45 expression (Beckman Coulter, Villepinte, France). Total lymphocytes were then gated on basis of their CD4 or CD8 expression and each sub-population was gated on CD25 and FoxP3 expression.
Statistical methods
Statistical analysis was performed using SPSS 15.0 software (SPSS Inc., Chicago, IL, USA). Quantitative variables were compared with non-parametric Wilcoxon test and Mann-Whitney U-test. The 2-tailed Spearman's correlation coefficient was used for comparisons within group. Principal Component Analysis (PCA) and linear univariate and multivariate regression analyses were also performed. P values less than 0.05 were considered significant. 
Results
Immunohistochemical analysis of intra-hepatic CD4 + FoxP3 + and CD8 + FoxP3 + cells
Analysis was performed in a sub-group of 20 patients who had similar characteristics than those of the whole population ( Table 1) . This procedure was adopted to visualize CD4, CD8 and FoxP3 single positive cells and CD4FoxP3 or CD8FoxP3 double positive cells ( Fig.1 ). CD4 + FoxP3 + co-stained cells were identified by a blue nuclear staining with anti-FoxP3 antibody, circled by a brown cytoplasmic membrane staining with anti-CD4 antibody. CD8 + FoxP3 + co-stained cells were characterized by brown nuclear staining with anti-FoxP3 antibody, circled by blue cytoplasmic membrane staining with anti-CD8 antibody. More than 99.5% of FoxP3 + cells were CD4 + cells ( Fig.1A,B ). Nevertheless, among slides from 20 patients, we only detected two persuasive CD8 + FoxP3 + cells (Fig.1G,H ). This suggests that CD8 + FoxP3 + cells are very scare in the liver and that the majority of FoxP3 + cells coexpress CD4. A considerable amount of FoxP3 + cells were observed in portal tracts and fibrous septa (Fig.1C) , particularly when lymphoid aggregates were present ( Fig.1D ). They were also observed in parenchymatous areas where they preferentially localized in necrotic areas in close contact with CD8 + T lymphocytes (Fig.1E,F) , suggesting contactdependent inhibition of the effector functions of CD8 + T cells by FoxP3 + cells.
Histological relationship between intra-hepatic FoxP3 + cells and CD4 + or CD8 + cells
Correlations between frequency and localization of FoxP3 + and CD4 + or CD8 + lymphocytes were studied. Cells were counted on an average of 50 fields (20 to 105) per liver biopsy. A significant correlation was found between the total number of FoxP3 + cells and the total number of CD4 + cells ( Fig.2A-r=0 .508-p=0.022) or the total number of CD8 + cells ( Fig.2B-r=0 .538-p=0.014). By multivariate linear regression analysis, only the correlation between total CD8 + and FoxP3 + cells remained significant (r=0.466-p=0.039). Correlations were also observed between the total number of FoxP3 + cells and the number of CD8 + cells in fibrotic and parenchymatous areas (r= 0.505-p=0.023 and r= 0.555-p=0.011 respectively, Fig.2C,D) . Moreover, the total number of FoxP3 + cells correlated with the number of FoxP3 + cells in the fibrotic tissue (r=0.923-p<0.001), the parenchymatous areas (r=0.777-p<0.001) and the necroinflammatory lesions (r=0.833-p<0.001). Interestingly, a strong correlation was observed between CD8 + lymphocytes and FoxP3 + cells in parenchymatous areas (r=0.511-p=0.021- Fig.2E ), especially inside the necro-inflammatory lesions (r=0.630-p=0.003- Fig.2F ), suggesting that FoxP3 + cells are mostly associated to CD8 + cells. Corroborating this point, 22% of FoxP3 + cells were present in the necro-inflammatory foci in contact with CD8 + cells or apoptotic bodies.
Quantitative RT-PCR analysis of intra-hepatic CD4, CD8, FoxP3 and IL-10
To extend our analysis, RT-PCR was performed on 47 liver biopsy samples for the quantification of CD4, CD8, FoxP3, IL-10, TGF-β, IFN-γ and TNF-α transcripts. Results were expressed as a ratio between the number of amplicons from the target gene and from HPRT gene. PCA determined the presence of gene clusters (Fig.3) . The most relevant correlations were observed between CD8 and FoxP3 (r=0.564-p=0.001- Fig.3A ), CD8 and IL-10 (r=0.405-p=0.022- Fig.3B ), TNF-α and TGF-β (r=0.652-p=0.005- Fig.3C ) and TGF-β and IL-10 (r=0.688-p<0.001- Fig.3D ). Moreover, pro-inflammatory cytokines TNFα and IFN-γ were also closely correlated to each other (r=0.496-p=0.004). Then, univariate and multivariate regression analyses were conducted for the correlated genes, with CD8 as the dependent variable and IL10, FoxP3, IFN-γ and TNF-α as .810-p<10 -6 )] and suggested that (i) when IL-10 expression increased by 1 unit, CD8 expression increased by 0.88 units, keeping the expression of FoxP3 and IFN-γ as constant (ii) when FoxP3 expression increased by 1 unit, CD8 expression decreased by 0.01 units, keeping the expression of IL-10 and IFN-γ as constant. Therefore, CD8, FoxP3 and IL-10 were linked together in the correlation circle of the PCA (Fig.3E,F) 
Flow cytometry detection and quantification of intra-hepatic CD4 + CD25 + FoxP3 + and CD8 + CD25 + FoxP3 + cells.
To precise the phenotype and the frequency of CD25 + FoxP3 + Treg observed by immunohistochemistry, flow cytometry analysis (Fig.4A,B) 
Fig.3. Relationship between expression levels of intra-hepatic immune markers. (A,B)
CD8 transcripts were significantly correlated with FoxP3 (A) and with IL-10 transcripts (B). (C,D) TGF-β transcripts were also strongly correlated with TNF-α (C) and with IL-10 transcripts (D). Principal Component Analysis (PCA) allowed defining gene expression clustering between CD8 and FoxP3 and IL-10 transcripts and between TGF-β and TNF-α and IL-10 transcripts. (E,F) PCA showed correlation circles of the most relevant clusters (E) and the correlation circle of the link between FoxP3, CD8 and IL-10 transcripts (F). Note that the first two factorial axes of the PCA analysis explain more than 80% of the total inertia. fresh liver tissues and PBMC providing from the 8 additional CHC patients, whose characteristics did not differ from those of the 47 other CHC patients ( Table 1) . Among intra-hepatic CD4 + lymphocytes, CD4 + CD25 + and CD4 + CD25 + FoxP3 + lymphocytes represented 6.0%±1.0% and 3.3%±1.5% respectively (Fig.4C) , underlining that CD4 + CD25 + FoxP3 + lymphocytes represented about 50% of CD4 + CD25 + lymphocytes.Thus, intra-hepatic CD4 + CD25 + FoxP3 + lymphocytes standed for less than 0.5% of the total intra-hepatic lymphocyte pool while no cell expressing CD8 + , CD25 + and FoxP3 + was detected in the liver. Frequencies for peripheral lymphocyte subsets are shown in the Table 3. . Table 3 Notethat less than 0.1% of peripheral CD8 + lymphocytes expressed CD25 + FoxP3 + . Similar analysis achieved on 3 uninfected-HCV biopsies showed that frequency of CD4 + CD25 + lymphocytes represented less than 0.1% of total lymphocytes and did not allow to detect CD4 + CD25 + FoxP3 + lymphocytes (data not shown).
. Quantification of intra-hepatic and peripheral lymphocytes in chronic HCVinfected patients (N=8)
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Relationship between immune markers and histological parameters.
We studied correlation between grade and stage of the disease according to the Metavir classification and intra-hepatic lymphocytes, quantitatively evaluated by immunohistochemical (n=20) and RT-PCR (n=47) analyses. Concerning Metavir necroinflammatory grade, it was correlated with the total number of CD4 + cells (r=0.526-p=0.017). The number of CD8 + cells was higher along with Metavir activity grades, however this trend was not statistically significant (p=0.073). FoxP3 + cells were two fold more abundant in livers with Metavir activity grade A1 than in those with Metavir grade A2, whereas their number was lower in livers with Metavir activity grade A3, but these differences were not statistically significant (Fig.5A,B) . RT-PCR analyses showed that CD8 (r=0.547-p=0.001) and IL-10 (r=0.318-p=0.040) transcripts were the only parameters significantly correlated with Metavir activity grade. Concerning Metavir fibrosis stage, it was correlated with (i) total number of CD4 + cells (r=0.713-p<0.001), (ii) total number of CD8 + cells (r=0.714-p<0.001), (iii) number of FoxP3 + cells in necro-inflammatory lesions (r=0.469-p=0.037), especially in piecemeal necrosis lesions (r=0.510-p=0.022). While the total number of CD8 + cells was significantly higher along with Metavir fibrosis stages, the total number of FoxP3 + cells was higher along with Metavir fibrosis stage F0 to stage F3 and was lower at the cirrhosis F4 stage in a non significantly way (Fig.5C,D) . In addition, Metavir fibrosis stage was only correlated with CD8 (r=0.481-p=0.005) and IL-10 (r=0.409-p=0.007) transcripts. Concerning the FoxP3 + /CD8 + cells ratio, it varied little from Metavir activity grade A1 to grade A3 and from Metavir fibrosis stage F0 to stage F3 (Fig.5E,F) . Strikingly, it was significantly lower at the cirrhosis stage (Metavir fibrosis stage F3 to stage F4, median range: 3.5 vs 1.3 -z=2.324-p=0.024) (Fig.5F) . Finally, it is worth to note that no correlation was found between serum viral load and any immune marker at cellular and transcriptional levels. CD4 + CD25 + FoxP3 + and CD4 + CD25 + FoxP3were calculated for samples of patients from the liver (white symbols) and from the blood (black symbols).
Discussion
HCV-specific T-cell responses are generally weak, narrowly focused and often dysfunctional in CHC [8, 9] . The current debate is to determine whether Treg population plays a role in the immune dysfunction. To date, because of difficulty in obtaining HCV-infected liver tissue, Treg were mainly studied in PBMC samples, on cells expanded in vitro after HCV peptides stimulation [28] . We thus focused our analysis on intra-hepatic Treg, in direct ex vivo condition. Three complementary approaches were combined in order to characterize their phenotype, frequency and localization, to search for relationships with other immune markers and to assess their potential role in CHC pathogenesis. The most important finding of our immunohistochemical study demonstrates that intra-hepatic Treg are mainly CD4 + FoxP3 + cells while CD8 + FoxP3 + cells are very scarce. This point is supported by our complementary flow cytometry analysis which does not detect CD8 + CD25 + FoxP3 + Treg in the liver samples. We confirm that CD8 + CD25 + FoxP3 + Treg are very low in blood as already published [27, 28, [33] [34] [35] and that the liver contains a population of CD4 + FoxP3 + which does not express CD25, as reported in HCV [36] and HBV [37] .
Another major immunohistochemical finding concerns the distribution of Treg in histological areas, showing that FoxP3 + cells are predominantly localized in piecemeal and lobular necroses, in contact with CD8 + T cells. In addition, we confirm that CD4 + FoxP3 + cells infiltrate the hepatic lymphoid aggregates, portal or septal tracts as well as parenchymatous lobules or nodules, in agreement with a previous study [38] . This would mean that Treg, within HCV-infected livers, have the direct access to interact with cytotoxic T cells at the site of action. Their plausible inhibitory role on the effector cells is supported by their localization together with CD8 + T cells, inside necro-inflammatory lesions. Furthermore, activated lymphocytes, either by viral or other antigens, which enter the liver are likely to encounter Treg since these cells are localized in portal tracts. The next step was to determine if the presence of Treg and CD8T cells was related to cytokines. Our RT-PCR analysis reveals significant correlations between FoxP3 and CD8 transcripts and IL-10, TGF-β, TNF-α and IFN-γ. Moreover, PCA indicates gene expression clustering of CD8 with FoxP3 and IL-10 and of TGF-β with TNF-α and IL-10. The low number of immune cells in the liver does not allow assessing the kind of cells producing these cytokines. However, it is now established that IL-10 is mainly produced by T cells with regulatory or suppressive functions [39, 40] . Secretion of TGF-β, also produced by Treg, is considered as an important factor for the local survival and function of natural Treg [11, 41] , but it also contributes to induction of fibrosis [42] . In vitro studies have demonstrated that both TGF-β and IL-10 inhibits the cytokine secretion and the cytotoxicity of CD8 + T lymphocytes [11, 43] . Considering our data and extrapolating the results achieved in PBMC, the correlation between the intrahepatic cytokines TGF-β and IL-10 might favor synergistic effects on each other in (i) maintaining the Treg pool and (ii) reducing pro-inflammatory cytokine secretions. It is known that TNF-α production is induced and up-regulated in the liver by NS3 of HCV [44] . TNF-α intervenes at an early stage of the cascade of events leading to liver damage [45] and is involved in the healing process including fibrogenesis [46] . As the majority (40/47) of patients included in our study have proven fibrosis, it was not surprising to detect high TNF-α expression in the liver of these patients. It has been also demonstrated that Treg inhibit in vitro production of IFN-γ by core specific CD4 + T cells and HCV-specific CD8 + T cells [13, 47] . As we found correlations between IL-10 and TGF-β, and between TNF-α and IFN-γ, one could speculate that the HCV inflammatory context favors production of both anti-inflammatory and pro-inflammatory cytokines. If Treg only partially inhibit the pool of intra-hepatic effector T cells, some effector cells could thus produce IFN-γ. These hypotheses are supported by previous data showing that IFNγ is released by effector T cells in HCV infection [3, 5, 6] . Whatever the balance between the four cytokines, our regression analysis highlights strong correlations between FoxP3, CD8 and IL-10. This would mean that FoxP3, CD8 and IL-10 altogether establish a beneficial equilibrium for both the host and the virus. On one hand, the host would gain benefit from Treg which restrain CD8 + T lymphocytes, thus preventing liver damage. On the other hand, the virus would be preserved through the suppression of Treg on CD8 + T cells.
It is important to note that the number of CD8 + T cells is higher along with the necro-inflammatory activity and fibrosis, whereas the number of Treg is high up to Metavir activity grade A2 and Metavir fibrosis stage F3 but is low after this grade and stage. Interestingly, the FoxP3 + /CD8 + cells ratio is significantly lower at the cirrhosis stage. In the light of these observations, the most likely scenario would be that, during the first steps of the disease, Treg modulate effector functions of T lymphocytes. During the cirrhosis end stage, when the tissue environment and the architecture are altered, Treg would be exhausted by the overflow of effector T cells. Interestingly, at different steps of the disease, no correlation was found between viral load and intra-hepatic Treg, suggesting that the essential role of Treg is to limit the CD8 + T cells pool. This would imply that the balance between Treg and effector lymphocytes is crucial to limit T lymphocytes-induced lesions. Therefore, the breakdown of equilibrium between FoxP3 and CD8T cells, up to stage F3, could appear to be a turning point in the course of the disease.
In conclusion, this study provides new insights in the phenotype of intra-hepatic Treg and their distribution in the different histological areas in chronic HCV-infected liver. It also suggests a link between Treg, CD8 and IL-10 which altogether could balance immune responses between the host and the virus, contributing to the viral persistence and preventing immunopathological liver tissue damages. It remains to determine whether the loss of Treg-CD8T cells interaction, beyond the stage F3, promotes an increase of cytolytic functions of CD8T lymphocytes, thus impacting on the expansion of liver damage.
